← Eichor
Study identifier: NCT06860971 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

Condition: Thyroid Cancer  ·  Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

PhasePhase 3
Planned participants144
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This study aims to demonstrate that, in subjects with locally advanced or metastatic iodine - refractory differentiated thyroid cancer who have failed previous VEGFR - targeted therapy, AL2846 can significantly prolong progression - free survival (PFS) compared with placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Feng Shi, Master  ·  0731 89762310  ·  3192279599@qq.com

Xiangqian Zheng, Doctor  ·  02223340123-3150  ·  xiangqian_zheng@163.com

Always discuss trial participation with your own doctor first.

Locations (35)

The Second Hospital Of Anhui Medical UniversityHefei, Anhui, ChinaNot Yet Recruiting
cancer hospital Chinese academy of medical sciencesBeijing, Beijing Municipality, ChinaNot Yet Recruiting
The Southwest Hospital of AmuChongqing, Chongqing Municipality, ChinaNot Yet Recruiting
Fujian Medical University Union HospitalFuzhou, Fujian, ChinaNot Yet Recruiting
Gansu Provincial Cancer HospitalLanzhou, Gansu, ChinaNot Yet Recruiting
Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, ChinaNot Yet Recruiting
Affiliated Hospital of Guilin Medical UniversityGui'lin, Guangxi, ChinaNot Yet Recruiting
The Second Affiliated Hospital Of GXUSTLiuzhou, Guangxi, ChinaNot Yet Recruiting
The First Affiliated Hospital of Hainan Medical UniversityHainan, Haikou, ChinaNot Yet Recruiting
CangZhou Center HospitalCangzhou, Hebei, ChinaNot Yet Recruiting
Harbin Medical University cancer hospitalHarbin, Heilongjiang, ChinaNot Yet Recruiting
Henan Cancer HospitalZhengzhou, Henan, ChinaNot Yet Recruiting

+ 23 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06860971